Clinical trials
Recruiting Phase 3 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 16 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Amgen | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
| Blokhin's Russian Cancer Research Center | 2 |
| Federation Francophone de Cancerologie Digestive | 2 |
| Fudan University | 2 |
| Regeneron Pharmaceuticals | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| BriaCell Therapeutics Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 50 |
| Neoplasm Metastasis | 6 |
| Neoplasms by Site | 5 |
| Lung Neoplasms | 4 |
| Urinary Bladder Neoplasms | 4 |
| Venous Thromboembolism | 4 |
| Brain Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colorectal Neoplasms | 3 |
| Glioblastoma | 3 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.